Cargando…

OR27-2 Growth Hormone Reduces Hepatic Steatosis, Inflammation and Fibrosis in Adults with Overweight/Obesity and Nonalcoholic Fatty Liver Disease

BACKGROUND: Overweight/obesity are associated with relative growth hormone (GH) deficiency, and GH deficiency has been implicated in the development of nonalcoholic fatty liver disease (NAFLD). NAFLD and its progressive form, nonalcoholic steatohepatitis (NASH), are associated with significant morbi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartsch, Lea, Bredella, Miriam, Chicote, Mark L, Colling, Caitlin, Corey, Kathleen, Drescher, Hannah, Haines, Melanie, Husseini, Jad, Kimball, Allison, Lauer, Georg, Long, Michelle, Miller, Karen, Simon, Tracey, Dichtel, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625227/ http://dx.doi.org/10.1210/jendso/bvac150.1093

Ejemplares similares

Expression of IGF-1, IGF-1 Receptor and Growth Hormone Receptor in Hepatic Tissue in Adults Across the Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
por: Dichtel, Laura E, et al.
Publicado: (2021)

MON-286 Peak Stimulated Growth Hormone Is Lower in Subjects with Nonalcoholic Fatty Liver Disease Than Controls of Similar Sex, Age and BMI
por: Dichtel, Laura E, et al.
Publicado: (2020)

Changes in Quality of Life After Long-Term Biochemical Control of Acromegaly
por: Kimball, Allison, et al.
Publicado: (2021)

MON-449 Serum Neuroactive Steroid Levels in Postmenopausal Women with Treatment-Resistant Major Depressive Disorder
por: Dichtel, Laura, et al.
Publicado: (2019)

SUN-303 Effects of Open-Label, Adjunctive Ganaxalone Treatment on Resistant Depression in Postmenopausal Women: A Pilot Study
por: Dichtel, Laura E, et al.
Publicado: (2020)

Growth Hormone Releasing Hormone Reduces Plasma Markers of Immune Activation and Hepatic Immune Pathways in Nonalcoholic Fatty Liver Disease
por: Stanley, Takara Leah, et al.
Publicado: (2021)

OR27-1 11-Oxygenated C19 Steroids Are the Predominant Androgens Responsible for Hyperandrogenemia in Cushing's Disease
por: Adaway, Jo, et al.
Publicado: (2022)

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study
por: East, Honey E, et al.
Publicado: (2022)

SUN-LB52 The Protective Effects of Hepatocyte GH Receptor (GHR) Signaling Against Steatosis and Liver Injury Is Sexually Dimorphic and Autonomous of IGF1
por: Sarmento-Cabral, Andre, et al.
Publicado: (2020)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

THU068 Evaluation Of Nonalcoholic Fatty Liver Disease, Liver Fibrosis And Serum Angiopoietin-like Protein Levels In Patients With Acromegaly
por: Eroglu, Imdat, et al.
Publicado: (2023)

SAT-243 Lymphocytic Hypophysitis Mimicking Pituitary Apoplexy in a 27-Year-Old Woman
por: Brooks, Danielle C, et al.
Publicado: (2020)

OR27-5 Malignancies in Prader-Willi Syndrome: Practical Recommendations Based on a Large International Cohort
por: Caixàs, Assumpta, et al.
Publicado: (2022)

MON-474 Dipeptidyl Peptidase-4 (DPP4) Inhibition Decreases Visceral Fat and Improves Glucose Metabolism in Overweight Women with Polycystic Ovarian Syndrome
por: Devin, Jessica, et al.
Publicado: (2019)

THU115 Sex-Specific And Shared Associations Between Vasopressin Levels And Body Composition In Adults With Obesity
por: Galbiati, Francesca, et al.
Publicado: (2023)

RF06 | PSAT171 Impact of GH Administration on Skeletal Endpoints in Adults with Overweight/Obesity
por: Dichtel, Laura, et al.
Publicado: (2022)

OR27-4 Placebo-Controlled and Open-Label Extension Study of a Novel Hepatic-Targeted Antisense Cimdelirsen (IONIS-GHR-LRx) Under Investigation in Acromegaly Patients
por: Bhanot, Sanjay, et al.
Publicado: (2022)

OR27-6 Effects of the SGLT2-Inhibitor Empagliflozin in Patients With Chronic Syndrome of Inadequate Antidiuresis (SIAD) - Results of a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial
por: Berres, Manfred, et al.
Publicado: (2022)

OR27-3 Long-Term Results from the Phase III LINC 4 Study: Osilodrostat Maintained Normal Mean Urinary Free Cortisol in Patients with Cushing's Disease, with a Favorable Safety Profile
por: Auchus, Richard J, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021)

MON-483 FOXO1 Contributes to Somatotrope Differentiation through Regulation of Key Transcription Factors
por: Stallings, Caitlin, et al.
Publicado: (2019)

Role of FOXO1 in Glucocorticoid-Induced Somatotrope Maturation
por: Das, Pratyusa, et al.
Publicado: (2021)

SUN-LB49 Chronic Exposure to Predator Odour Stress Disrupts LH Pulsatility and Delays Puberty While Activation of Amygdala Kisspeptin Advances Puberty
por: Ivanova, Deyana, et al.
Publicado: (2020)

RF01 | PMON45 Urocortin 3 Interaction with GABA and Glutamate in the Posterodorsal Subnucleus of The Medial Amygdala Mediates Suppression of GnRH Pulse Generator Frequency in Female Mice
por: Ivanova, Deyana, et al.
Publicado: (2022)

OR32-05 Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men
por: Maso, Ana Aulinas, et al.
Publicado: (2020)

OR17-2 GABAergic Signalling in the Posterodorsal Medial Amygdala Mediates Psychological Stress-induced Suppression of the GnRH Pulse Generator in Female Mice
por: DeBurgh, Ross, et al.
Publicado: (2022)

FRI339 Hypophysitis Secondary To Small Vessel Anca Vasculitistreated With Rituximab
por: Carmen Rivadeneira, Ana Del, et al.
Publicado: (2023)

FRI368 Thyroid Paraganglioma: A Rare Manifestation Of Paraganglioma Syndrome Associated With SDHD Mutation
por: Samuel, Kelara, et al.
Publicado: (2023)

MON-453 Endocrine, Bone, and Metabolic Disorders in Adults after Allogeneic Stem-Cell Transplant
por: Demeocq, Vianney, et al.
Publicado: (2019)

MON-486 Prolactin Reduces the Hyperoxia-Induced Inhibition of Retinal Neovascularization in Newborn Mice
por: Vazquez-Membrillo, Miguel, et al.
Publicado: (2019)

MON-435 The Responsiveness To Ddavp Test Predicts Usp8 Mutation In Patients With Cushing's Disease
por: Shichi, Hiroki, et al.
Publicado: (2019)

MON-427 An Interesting Case of Drug-Induced Hyperprolactinemia in a Patient Who Presented with Psychosis
por: Siddiqi, Asmat, et al.
Publicado: (2019)

MON-LB077 A Large Single Institution Series of Neuroendocrine Recovery and Tumor Recurrence after Pituitary Apoplexy
por: Brown, Teresa, et al.
Publicado: (2019)

MON-440 Cyberknife Radiosurgery for Functional and Non-Functional Pituitary Adenomas: Long-Term Single-Center Experience
por: Yuen, Kevin, et al.
Publicado: (2019)

MON-456 Determinants of Hypothalamic Obesity Following Surgical Treatment for Craniopharyngioma in Adults
por: Hong, A Ram, et al.
Publicado: (2019)

MON-416 A Novel Approach to Ectopic Adrenal Tissue in Nelson's Syndrome
por: Martirossian, Alexandra, et al.
Publicado: (2019)

MON-445 Long-Term Results of an Ongoing Non-Interventional, Real-World Observational Study of Pasireotide SC in Cushing's Disease
por: Yuen, Kevin, et al.
Publicado: (2019)

MON-451 Growth Hormone Deficiency (GHD) over 4 Years after Mild Traumatic Brain Injury (mTBI) in Deployed Veterans: Interim Review
por: Win, Htet Htet, et al.
Publicado: (2019)

MON-468 Selective Inhibition of Epigenetic Pathways Has Anti-Proliferative and Pro-Apoptotic Effects on the Mouse Corticotroph Tumor Cells, AtT20
por: Lines, Kate, et al.
Publicado: (2019)

MON-421 A Case of Central Diabetes Insipidus in a Patient with Myxopapillary Ependymoma and GFAP Paraneoplastic Autoimmune Meningoencephalomyelitis
por: Lee, Christine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5crdne98b2okn1ksc73oa22ov9